FYR Bio, a biotechnology company leveraging extracellular vesicles (EVs) to create an end-to-end solution for new precision medicine tools, announced it has closed a new $8 million round of funding. The Sontag Innovation Fund (a venture subsidiary of The Sontag Foundation) and the Yuvaan Tiwari Foundation join long-standing investor Two Bear Capital. Proceeds will accelerate FYR's continued expansion in oncology and added emphasis in neuroscience, including neuro-oncology and neurodegeneration.